- Report
- June 2022
- 43 Pages
Global
From €1901EUR$2,000USD£1,597GBP
- Report
- November 2021
- 80 Pages
Africa
From €1901EUR$2,000USD£1,597GBP
- Report
- November 2021
- 40 Pages
Brazil
From €1426EUR$1,500USD£1,198GBP
- Report
- November 2021
- 40 Pages
China
From €1426EUR$1,500USD£1,198GBP
- Report
- November 2021
- 40 Pages
France
From €1426EUR$1,500USD£1,198GBP
- Report
- November 2021
- 40 Pages
Germany
From €1426EUR$1,500USD£1,198GBP
- Report
- November 2021
- 40 Pages
Ireland
From €1426EUR$1,500USD£1,198GBP
- Report
- November 2021
- 40 Pages
Japan
From €1426EUR$1,500USD£1,198GBP
- Report
- November 2021
- 40 Pages
Russia
From €1426EUR$1,500USD£1,198GBP
- Report
- November 2021
- 40 Pages
South Korea
From €1426EUR$1,500USD£1,198GBP
- Report
- November 2021
- 40 Pages
United States
From €1426EUR$1,500USD£1,198GBP
- Report
- November 2021
- 40 Pages
Vietnam
From €1426EUR$1,500USD£1,198GBP
- Report
- October 2022
- 281 Pages
Global
From €3394EUR$3,570USD£2,851GBP

Hyperhidrosis is a medical condition characterized by excessive sweating. It is a common disorder that affects millions of people worldwide. Endocrinology is the branch of medicine that deals with the diagnosis and treatment of disorders related to hormones and the endocrine system. Hyperhidrosis is a disorder that is often treated by endocrinologists.
The hyperhidrosis drug market is a rapidly growing segment of the endocrinology market. It is driven by the increasing prevalence of hyperhidrosis, the availability of new treatments, and the growing awareness of the condition. The market is expected to grow at a steady rate in the coming years due to the increasing demand for effective treatments.
Some of the major companies in the hyperhidrosis drug market include GlaxoSmithKline, Merck & Co., Pfizer, Johnson & Johnson, and Novartis. These companies are actively involved in the development and marketing of drugs for the treatment of hyperhidrosis. Show Less Read more